89bio to present at upcoming investor conferences

San francisco, may 05, 2021 (globe newswire) -- 89bio, inc. (nasdaq: etnb), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced that company's management will provide a corporate update and participate in one-on-one investor meetings at the bofa securities 2021 health care conference on thursday, may 13, 2021 at 1:15 pm et and the rbc capital markets 2021 global healthcare conference on wednesday, may 19, 2021 at 9:45 am et.
ETNB Ratings Summary
ETNB Quant Ranking